SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-100828
Filing Date
2022-09-16
Accepted
2022-09-16 16:18:12
Documents
15
Period of Report
2022-09-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2225927d2_8k.htm   iXBRL 8-K 28997
2 EXHIBIT 5.1 tm2225927d2_ex5-1.htm EX-5.1 9445
3 GRAPHIC tm2225927d2_ex5-1img001.jpg GRAPHIC 7790
4 GRAPHIC tm2225927d2_ex5-1img002.jpg GRAPHIC 24632
  Complete submission text file 0001104659-22-100828.txt   259978

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA atxs-20220916.xsd EX-101.SCH 3036
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20220916_lab.xml EX-101.LAB 34476
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20220916_pre.xml EX-101.PRE 22597
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2225927d2_8k_htm.xml XML 3603
Mailing Address 75 STATE STREET SUITE 1400 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 1400 BOSTON MA 02109 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 221248269
SIC: 2834 Pharmaceutical Preparations